Ameriprise’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Ameriprise's NUVB Position: Q3 2026 in Review
Ameriprise opened a new position in Nuvation Bio (NUVB) in Q3 2026: 110,852 shares worth $621K. The stake represents ﹤0.01% of the portfolio and ranks #3635 among its holdings. This is a return to the name: Ameriprise previously reported a position in NUVB as recently as Q4 2025.
Ameriprise first reported a position in NUVB in Q1 2021 and has held it in 12 quarters since. The position peaked at $7.61M in Q1 2021. 260 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Ameriprise held 110,852 shares of Nuvation Bio worth $621K as of Q3 2026.
- Nuvation Bio was a new Ameriprise position in Q3 2026.
- Nuvation Bio made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #3635 holding.
- Ameriprise first reported a position in Nuvation Bio in Q1 2021 and has held it in 12 quarters since.
- Ameriprise's Nuvation Bio position peaked at $7.61M in Q1 2021.
- 260 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.